Our Pricing

Access Mounjaro NHS Prescription Weight Loss Injections

Accessing Mounjaro NHS prescription weight loss injections UK through a registered online pharmacy offers the same clinical rigour as traditional GP services, with convenient home delivery from £135.00. At Cured Pharmacy, our UK-registered prescribers conduct comprehensive assessments to determine whether tirzepatide treatment is clinically appropriate for your weight management goals, following MHRA and NICE guidance throughout.

How Mounjaro Weight Loss Injections Work

Mounjaro contains tirzepatide, the first dual GIP/GLP-1 receptor agonist licensed by the MHRA for chronic weight management in the UK [1]. Unlike single-pathway treatments such as semaglutide, tirzepatide activates both glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors, producing enhanced effects on appetite regulation, insulin secretion, and energy expenditure.

In the pivotal SURMOUNT-1 trial, participants receiving the 15mg maintenance dose achieved an average body weight reduction of 22.5% over 72 weeks, compared to 2.4% in the placebo group [1]. This dual-agonist mechanism appears to produce greater weight loss outcomes than GLP-1 agonists alone, though individual results vary based on adherence, lifestyle modifications, and metabolic factors [2].

Tirzepatide works by slowing gastric emptying, reducing appetite signals in the hypothalamus, and improving insulin sensitivity. Most patients report decreased hunger and earlier satiety within the first two weeks of treatment, though full therapeutic effects typically develop over 16-20 weeks as doses are gradually titrated upward under prescriber supervision.

NHS Prescription Requirements for Mounjaro

Mounjaro is a prescription-only medicine (POM) in the UK, requiring clinical assessment by a registered prescriber before dispensing. NICE guidelines recommend GLP-1 receptor agonists for adults with a BMI ≥30 kg/m², or ≥27 kg/m² with at least one weight-related comorbidity such as type 2 diabetes, hypertension, or obstructive sleep apnoea [3].

At Cured Pharmacy, our online consultation replicates the clinical assessment you would receive from an NHS GP. Our UK-registered prescribers (working under superintendent pharmacist Tarun Kumar, GPhC 2233073) review your medical history, current medications, cardiovascular risk factors, and weight management goals before determining suitability. The consultation typically takes under three minutes to complete, with prescribing decisions made within 24 hours.

Patients with a history of medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2, severe gastrointestinal disease, or diabetic retinopathy require additional specialist assessment before tirzepatide can be prescribed. Our clinical team follows MHRA safety guidance and may recommend alternative treatments if Mounjaro is not clinically appropriate for your circumstances.

What the Online Assessment Covers

Your clinical questionnaire will assess current weight and BMI, previous weight loss attempts, existing medical conditions (particularly thyroid, pancreatic, and cardiovascular history), current prescription medications, and any history of eating disorders or mental health conditions that may affect treatment suitability. Honest, complete answers ensure safe prescribing and optimal treatment outcomes.

Mounjaro Dosing Schedule and Administration

Mounjaro treatment begins with a 2.5mg subcutaneous injection once weekly for four weeks, allowing your body to adapt to the medication and minimising gastrointestinal side effects. Your prescriber will then increase the dose in 2.5mg increments every four weeks, typically reaching a maintenance dose of 10mg or 15mg depending on weight loss response and tolerability [1].

Each KwikPen is pre-filled and designed for single-patient use, with a built-in needle that makes self-administration straightforward. Injections are given subcutaneously in the abdomen, thigh, or upper arm, rotating sites weekly to reduce injection-site reactions. Most patients find the process simple after the first one or two administrations, and our clinical team provides detailed injection technique guidance with your first prescription.

Consistency is essential for optimal results. Choose a day of the week that fits your routine and administer your injection on that day each week, within a 3-day window if necessary. Store unused pens in the refrigerator at 2-8°C, and never freeze. Once in use, pens may be kept at room temperature (up to 30°C) for up to 21 days.

What to Expect During Dose Escalation

Mild nausea, reduced appetite, and occasional loose stools are common during the first few weeks of each new dose level, typically resolving within 7-10 days as your body adjusts. Eating smaller, more frequent meals and avoiding high-fat foods can minimise these effects. If side effects persist or worsen, contact your prescriber before your next dose increase.

Comparing Weight Loss Injection Options

Several injectable weight loss treatments are now licensed in the UK, each with distinct mechanisms, dosing schedules, and clinical trial data. Mounjaro (tirzepatide) offers dual GIP/GLP-1 receptor agonism, while Wegovy and Saxenda work through GLP-1 pathways alone. Understanding these differences helps you and your prescriber select the most appropriate option.

Wegovy (semaglutide) demonstrated an average 14.9% body weight reduction over 68 weeks in the STEP-1 trial, making it highly effective though typically producing less weight loss than tirzepatide at equivalent trial durations [4]. Wegovy is also administered once weekly and follows a similar dose-escalation protocol. Saxenda (liraglutide) requires daily injections and showed an average 8% weight reduction over 56 weeks in the SCALE trial [5].

Your prescriber will consider factors including your weight loss goals, injection frequency preference, previous treatment response, budget, and any contraindications when recommending a specific medication. All three options require ongoing lifestyle modifications including calorie reduction and increased physical activity for optimal outcomes.

Expected Weight Loss Results and Timeline

Clinical trial data shows that patients on Mounjaro 15mg achieved an average 22.5% total body weight reduction over 72 weeks, with most weight loss occurring between weeks 12 and 52 [1]. However, individual results vary significantly based on starting weight, adherence to treatment, dietary modifications, physical activity levels, and metabolic factors.

Most patients notice appetite suppression and early satiety within the first two weeks of treatment, even at the 2.5mg starting dose. Measurable weight loss typically begins in weeks 4-8, accelerating as doses increase. Patients who combine tirzepatide with a structured nutrition plan and regular exercise (150+ minutes weekly of moderate activity) tend to achieve results at the higher end of clinical trial ranges [6].

Weight loss plateaus are common around months 6-9 of treatment and do not indicate treatment failure. Continuing your prescribed dose, reassessing calorie intake, and increasing activity levels often restart progress. Your prescriber may adjust your maintenance dose or recommend additional metabolic assessments if weight loss stalls for more than 8-12 weeks despite adherence.

Maintaining Weight Loss Long-Term

Research indicates that discontinuing GLP-1 receptor agonists often leads to weight regain, with patients regaining approximately two-thirds of lost weight within one year of stopping treatment [7]. Long-term maintenance typically requires continued medication alongside sustained lifestyle changes, regular physical activity, and ongoing clinical monitoring to preserve metabolic improvements achieved during active treatment.

Pricing and Accessing Mounjaro Through Cured Pharmacy

Mounjaro is available at Cured Pharmacy from £135.00 with transparent upfront pricing displayed before your clinical consultation. This includes the medication, UK prescriber assessment, and discreet home delivery. We guarantee the lowest prices in the UK for genuine, MHRA-licensed medicines, with no hidden fees or subscription requirements.

Your first consultation is completely free and takes under three minutes to complete online. Once your prescriber approves treatment, you'll receive a prescription valid for up to six months, allowing you to reorder conveniently without repeating the full assessment (subject to ongoing suitability checks). We also offer weight loss treatment bundles that provide additional savings when ordering multiple months' supply.

All Mounjaro pens dispensed by Cured Pharmacy are sourced directly from UK-licensed wholesalers and stored in our GPhC-registered pharmacy (registration number 9012511) under controlled temperature conditions. Every package is dispatched in plain, discreet packaging with no external pharmacy branding, arriving via tracked courier within 1-3 working days of prescriber approval.

Scientific References

1. Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine, 387(3), 205–216. https://doi.org/10.1056/NEJMoa2206038
2. Frias, J. P., Davies, M. J., Rosenstock, J., et al. (2021). Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes. New England Journal of Medicine, 385(6), 503–515. https://doi.org/10.1056/NEJMoa2107519
3. National Institute for Health and Care Excellence. (2023). Obesity: identification, assessment and management (CG189). NICE. https://www.nice.org.uk/guidance/cg189
4. Wilding, J. P. H., Batterham, R. L., Calanna, S., et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989–1002. https://doi.org/10.1056/NEJMoa2032183
5. Pi-Sunyer, X., Astrup, A., Fujioka, K., et al. (2015). A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management. New England Journal of Medicine, 373(1), 11–22. https://doi.org/10.1056/NEJMoa1411892
6. Wadden, T. A., Bailey, T. S., Billings, L. K., et al. (2021). Effect of Subcutaneous Semaglutide vs Placebo as an Adjunct to Intensive Behavioral Therapy on Body Weight in Adults With Overweight or Obesity. JAMA, 325(14), 1403–1413. https://doi.org/10.1001/jama.2021.1831
7. Wilding, J. P. H., Batterham, R. L., Davies, M., et al. (2022). Weight regain and cardiometabolic effects after withdrawal of semaglutide: The STEP 1 trial extension. Diabetes, Obesity and Metabolism, 24(8), 1553–1564. https://doi.org/10.1111/dom.14725

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication. Individual results may vary, and weight loss outcomes depend on adherence to treatment, lifestyle modifications, and individual metabolic factors.